Daewoong, Almirall enter into licensing agreement for new COPD treatment
Aclidinium bromide is a novel, long-acting inhaled muscarinic antagonist currently being developed as a mainten...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
